The Somatotropic Axis Set pairs GHRH analogues with growth hormone secretagogues so the pathway can be probed at more than one point. CJC-1295 No DAC, Ipamorelin, Sermorelin and MOTS-C are supplied together for pituitary and metabolic cell work.
- CJC-1295 No DAC 10mg vial, a tetra-substituted analogue of GHRH (1-29)
- Ipamorelin 10mg vial, a selective pentapeptide agonist at the ghrelin receptor GHS-R1a
- Sermorelin 5mg vial, the GHRH (1-29) fragment
- MOTS-C 10mg vial, a sixteen amino acid peptide encoded in mitochondrial DNA
Somatotropic Axis Set research applications
- cAMP accumulation in pituitary somatotrophs, with Sermorelin as the unmodified GRF(1-29) comparator for CJC-1295 No DAC
- Calcium mobilisation and IP-One assays in GHS-R1a expressing HEK293 or CHO lines, the Ipamorelin arm
- Western blot for phospho-Thr172 AMPK and phospho-ACC in myoblasts or myotubes, the MOTS-C readout
Research profiles: CJC-1295, Ipamorelin, Sermorelin and MOTS-C
What is tested in this set
This set contains four products, each supplied in its own vial and each tested on its own. The table lists the published result for every component.
| Component | Purity | Laboratory | Analysed | Certificate |
|---|---|---|---|---|
| Ipamorelin | 99.71% | Janoshik Analytical | 9 Jul 2026 | View |
| Sermorelin | 99.31% | Janoshik Analytical | 10 Apr 2026 | View |
| CJC-1295 No DAC | 99.46% | Janoshik Analytical | 9 Jul 2026 | View |
| MOTS-C | 99.28% | Janoshik Analytical | 24 Sep 2026 | View |









